Selected adverse events reported after COVID-19 vaccination

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Mar. 7, 2023
  
  CDC’s Vaccine Safety Datalink (VSD) met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. To date, no other safety systems have shown a similar signal and multiple subsequent analyses have not validated this signal. No change is recommended in COVID-19 vaccination practice.
  
  
• Content Notes:
  What You Need to Know -- Anaphylaxis after COVID-19 Vaccination -- Reports of Deaths after COVID-19 Vaccination -- Guillain-Barré Syndrome (GBS) after COVID-19 Vaccination -- Myocarditis and Pericarditis after COVID-19 Vaccination -- Thrombosis with Thrombocytopenia Syndrome (TTS) after COVID-19 Vaccination.
• Subjects:
  Cause Of Death Coronavirus Infections/mortality COVID-19 Vaccines/adverse Effects COVID-19/mortality Death Certificates Heart Diseases/mortality Mortality Neoplasms/mortality Pandemics Vital Statistics
• Document Type:
  Webpage
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:a5b5e7b652beeffc09f8cfdc9b6bf2ac4e31414400e9e02404caf6b97ef05f4d
• Download URL:
  https://stacks.cdc.gov/view/cdc/132657/cdc_132657_DS1.pdf
• File Type:
  [PDF - 871.96 KB ]